United States · Funded startup

Who invested in Carbylan Therapeutics

4 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 31 Oct 2026

$35Mraised across 4 rounds since 2007, from 4 sources

$20MSeries B$6.0MSeries B$5.0MDebt$4.0MDebt
Latest round
Debt, $4.0MMar 2015
Biggest round
$20MSeries B · Nov 2007
Investors
3
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2009201120132015
$20MSeries B$6.0MSeries B$5.0MDebt$4.0MDebt
First round
Series B, $20M
Nov 2007
Biggest round
$20M
Series B · Nov 2007
Usual gap between rounds
21 months
the median of 3

The rounds

  1. Mar 2015
    Debt$4.0M

    No investor was named in the report.

    From a historical funding recordSEC filing: $4.0M sold, first sale Feb 2015

  2. Oct 2014
    Debt$5.0M

    No investor was named in the report.

    From a historical funding recordSEC filing: $5.0M sold, first sale Sept 2014

  3. Jan 2013
  4. Nov 2007

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series B2007Series B2013Debt2014Debt2015InterWest PartnersAlta PartnersVivo Ventures

Everyone who backed them

InterWest PartnersVC firm2rounds
Alta PartnersVC firm2rounds
Vivo VenturesVC firm2rounds

Missing a round, or an investor who was in one? Tell us.

Quick answers about Carbylan Therapeutics

Who invested in Carbylan Therapeutics?

Carbylan Therapeutics's investors include InterWest Partners, Alta Partners and Vivo Ventures.

How much has Carbylan Therapeutics raised?

Carbylan Therapeutics has raised $35M across 4 rounds since 2007.

When did Carbylan Therapeutics last raise?

Carbylan Therapeutics's most recent round was a Debt of $4.0M in Mar 2015.

What was Carbylan Therapeutics's biggest round?

Carbylan Therapeutics's largest round on record is $20M (Series B), in Nov 2007.

Who backed Carbylan Therapeutics first?

Carbylan Therapeutics's first round on record, in Nov 2007, was backed by InterWest Partners, Alta Partners and Vivo Ventures.

What stage is Carbylan Therapeutics at?

Carbylan Therapeutics's latest named round is a Debt, in Mar 2015.

Where is Carbylan Therapeutics based?

Carbylan Therapeutics is based in the United States.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.